Caption Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 793 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 837 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 787 |
|
|
2024
Q3 | – | Sell |
-4,065
| Closed | -$75.9K | – | 676 |
|
|
2024
Q2 | $75.9K | Sell |
4,065
-1,935
| -32% | -$36.1K | ﹤0.01% | 331 |
|
|
2024
Q1 | $118K | Buy |
+6,000
| New | +$118K | ﹤0.01% | 294 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 693 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 633 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 589 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 609 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 661 |
|
|
2022
Q3 | – | Sell |
-1,184
| Closed | -$11K | – | 719 |
|
|
2022
Q2 | $11K | Sell |
1,184
-64,439
| -98% | -$599K | ﹤0.01% | 463 |
|
|
2022
Q1 | $651K | Buy |
65,623
+64,358
| +5,088% | +$638K | 0.01% | 299 |
|
|
2021
Q4 | $14K | Sell |
1,265
-16,235
| -93% | -$180K | ﹤0.01% | 533 |
|
|
2021
Q3 | $199K | Buy |
17,500
+5,500
| +46% | +$62.5K | ﹤0.01% | 433 |
|
|
2021
Q2 | $168K | Sell |
12,000
-22,340
| -65% | -$313K | ﹤0.01% | 352 |
|
|
2021
Q1 | $635K | Buy |
+34,340
| New | +$635K | 0.01% | 201 |
|
|
2020
Q4 | – | Sell |
-7,500
| Closed | -$116K | – | 507 |
|
|
2020
Q3 | $116K | Buy |
+7,500
| New | +$116K | ﹤0.01% | 297 |
|